Literature DB >> 19544015

High-resolution two-dimensional electrophoresis.

Walter Weiss1, Angelika Görg.   

Abstract

Two-dimensional gel electrophoresis (2-DE) with immobilized pH gradients (IPGs) combined with protein identification by mass spectrometry is currently the workhorse for the majority of ongoing proteome projects. Although alternative/complementary technologies, such as MudPIT, ICAT, or protein arrays, have emerged recently, there is up to now no technology that matches 2-DE in its ability for routine parallel expression profiling of large sets of complex protein mixtures. 2-DE delivers a map of intact proteins, which reflects changes in protein expression level, isoforms, or post-translational modifications. High-resolution 2-DE can resolve up to 5,000 proteins simultaneously ( approximately 2,000 proteins routinely), and detect and quantify <1 ng of protein per spot. Today's 2-DE technology with IPGs has largely overcome the former limitations of carrier ampholyte-based 2-DE with respect to reproducibility, handling, resolution, and separation of very acidic or basic proteins. Current research to further advance 2-DE technology has focused on improved solubilization/separation of hydrophobic proteins, display of low abundance proteins, and reliable protein quantitation by fluorescent dye technologies. Here, we provide a comprehensive protocol of the current high-resolution 2-DE technology with IPGs for proteome analysis and describe in detail the individual steps of this technique, i.e., sample preparation and protein solubilization, isoelectric focusing in IPG strips, IPG strip equilibration, and casting and running of multiple SDS gels. Last but not the least, a section on how to circumvent the major pitfalls is included.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19544015     DOI: 10.1007/978-1-60761-157-8_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  15 in total

1.  Genome-wide targeting of the epigenetic regulatory protein CTCF to gene promoters by the transcription factor TFII-I.

Authors:  Rodrigo Peña-Hernández; Maud Marques; Khalid Hilmi; Teijun Zhao; Amine Saad; Moulay A Alaoui-Jamali; Sonia V del Rincon; Todd Ashworth; Ananda L Roy; Beverly M Emerson; Michael Witcher
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

Review 2.  Application of proteomics to the study of polycystic ovary syndrome.

Authors:  M Insenser; H F Escobar-Morreale
Journal:  J Endocrinol Invest       Date:  2011-11-21       Impact factor: 4.256

3.  Liquid Chromatography Mass Spectrometry-Based Proteomics: Biological and Technological Aspects.

Authors:  Yuliya V Karpievitch; Ashoka D Polpitiya; Gordon A Anderson; Richard D Smith; Alan R Dabney
Journal:  Ann Appl Stat       Date:  2010       Impact factor: 2.083

4.  Phenotyping breast cancer cell lines EM-G3, HCC1937, MCF7 and MDA-MB-231 using 2-D electrophoresis and affinity chromatography for glutathione-binding proteins.

Authors:  Jana Mladkova; Miloslav Sanda; Eva Matouskova; Irena Selicharova
Journal:  BMC Cancer       Date:  2010-08-23       Impact factor: 4.430

Review 5.  Current challenges in software solutions for mass spectrometry-based quantitative proteomics.

Authors:  Salvatore Cappadona; Peter R Baker; Pedro R Cutillas; Albert J R Heck; Bas van Breukelen
Journal:  Amino Acids       Date:  2012-07-22       Impact factor: 3.520

6.  Skeletal muscle proteomics: current approaches, technical challenges and emerging techniques.

Authors:  Kay Ohlendieck
Journal:  Skelet Muscle       Date:  2011-02-01       Impact factor: 4.912

7.  Beyond genetic factors in familial amyloidotic polyneuropathy: protein glycation and the loss of fibrinogen's chaperone activity.

Authors:  Gonçalo da Costa; Ricardo A Gomes; Ana Guerreiro; Élia Mateus; Estela Monteiro; Eduardo Barroso; Ana V Coelho; Ana Ponces Freire; Carlos Cordeiro
Journal:  PLoS One       Date:  2011-10-28       Impact factor: 3.240

8.  Plasma Proteomic Profiling in Hereditary Breast Cancer Reveals a BRCA1-Specific Signature: Diagnostic and Functional Implications.

Authors:  Domenica Scumaci; Laura Tammè; Claudia Vincenza Fiumara; Giusi Pappaianni; Antonio Concolino; Emanuela Leone; Maria Concetta Faniello; Barbara Quaresima; Enrico Ricevuto; Francesco Saverio Costanzo; Giovanni Cuda
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

9.  Transthyretin Amyloidosis: Chaperone Concentration Changes and Increased Proteolysis in the Pathway to Disease.

Authors:  Gonçalo da Costa; Cristina Ribeiro-Silva; Raquel Ribeiro; Samuel Gilberto; Ricardo A Gomes; António Ferreira; Élia Mateus; Eduardo Barroso; Ana V Coelho; Ana Ponces Freire; Carlos Cordeiro
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

Review 10.  Proteomic profiling of the dystrophin-deficient mdx phenocopy of dystrophinopathy-associated cardiomyopathy.

Authors:  Ashling Holland; Kay Ohlendieck
Journal:  Biomed Res Int       Date:  2014-03-20       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.